Search Results
Lung cancer highlights from ASCO 2017 | John Heymach
ASCO 2019 - John Conibear
AACR 2023 highlights on advances in the neoadjuvant treatment of resectable NSCLC with John Heymach
Expert highlights: Lung cancer research from ASCO 2018 | Lecia Sequist
ASCO 2019 - Dr Tom Newsom-Davis
Dr. Heymach on the Significance of Nivolumab for Lung Cancer
Dr. Heymach on New KRAS Subsets in Lung Cancer
A 68-Year-Old Man With Metastatic EGFR+ NSCLC
Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer treatment
ASCO 2019: Dr. Horn Highlights Progress in Lung Cancer
ASCO 2023 Expert Report on novelties in oncogene driven NSCLC by A. Curioni-Fontecedro
ICAHO20 - ASCO Directâ„¢ Highlights - Dr. Kathryn Gold - Lung Cancer Rapid Fire Q&A